New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets | Business Wire
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
TEVA 5343 Pill White Elliptical/Oval - Drugs.com
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva recalls US-made drugs following contamination fears - The Boston Globe
Texas AG announces $225M opioid settlement with Teva Pharmaceutical Industries | kvue.com